What is xylazine, the White House's response and more with Rahul Gupta, MD, MPH

The Biden-Harris administration designated fentanyl combined with xylazine as an emerging threat to the U.S. Rahul Gupta, MD, MPH, director of the White House Office of National Drug Control Policy, joins to discuss what xylazine is, the threat is poses, the White House’s plan to combat it and how physicians can help. American Medical Association CXO Todd Unger hosts. 💪 Get involved in the fight to end the overdose epidemic: https://end-overdose-epidemic.org/ 📨 Stay up to date on all the latest advocacy news by subscribing to AMA Advocacy Update: https://bit.ly/AMA_AdvocacyUpdate 🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew